Immunotherapy holds great promise, but it only works in a subset of cancer patients. To predict which patients will respond positively to certain treatments and track their progress, researchers search for predictive and prognostic immuno-oncology biomarkers.
In this virtual symposium brought to you by The Scientist, an expert panel will discuss their efforts to identify new biomarkers for various cancers, including non-small cell lung cancer (NSCLC) and clear cell renal cell carcinoma (ccRCC). They will also highlight the cutting-edge technologies they use to develop clinical applications for these biomarkers.
10:30 AM – Introduction
10:40 AM – An Immune Cell Signature to Predict Patient Responses to Immunotherapy Thomas U. Marron, MD, PhD
11:10 AM – How Computational Modeling Informs Trial Design and Biomarker Discovery Johannes Textor, PhD
11:40 AM – Anti-PD-1 Response and Resistance Determinants in Clear Cell Renal Cell Carcinoma Lewis Au, MD, PhD
12:10 PM – Cancer Proteogenomics to Understand Immune Evasion and Discover Drug Targets Janne Lehtiö, PhD
12:40 PM – Open panel Q&A session
Thursday, May 12, 2022
10:30 AM - 1:30 PM Eastern Time
Meet the speakers
Thomas U. Marron, MD, PhD Director, Early Phase Trials Unit The Tisch Cancer Institute Associate Professor of Medicine Icahn School of Medicine at Mount Sinai
Johannes Textor, PhD Associate Professor Tumor Immunology Department Radboud University Medical Center Group Leader Institute for Computing Information Sciences Radboud University
Lewis Au, MD, PhD Clinical Research Fellow Royal Marsden Hospital Translational Research Scientist Francis Crick Institute
Janne Lehtiö, PhD Professor Department of Oncology and Pathology Karolinska Institute and SciLifeLab
TS_Webinar_Symposium_Biomarkers on the Brain: From Sequencing to Functional Imaging December 13, 2021
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: firstname.lastname@example.org